Langerhans cell origin and regulation

Current Opinion in Hematology

Volumn 23, Issue 1, 2016, Pages 28-35

  Collin, Matthew ^a   Milne, Paul ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dendritic cell; Langerhans cell; Transforming growth factor beta

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BONE MARROW; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CELL SELF-RENEWAL; DENDRITIC CELL; EMBRYO DEVELOPMENT; FETUS LIVER; HEMATOPOIESIS; HOMEOSTASIS; HUMAN; INFLAMMATION; LANGERHANS CELL; MACROPHAGE; MONOCYTE; NONHUMAN; ONTOGENY; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; YOLK SAC; ANIMAL; CELL LINEAGE; CYTOLOGY; FETUS; GENETICS; IMMUNOLOGY; LANGERHANS CELL HISTIOCYTOSIS; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SELF RENEWAL; FETUS; HISTIOCYTOSIS, LANGERHANS-CELL; HOMEOSTASIS; HUMANS; INFLAMMATION; LANGERHANS CELLS; LIVER; MACROPHAGES; MONOCYTES; STEM CELLS; YOLK SAC;

EID: 84952632023     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000202     Document Type: Review

References (66)

1. Romani N, Brunner PM, Stingl G. Changing views of the role of Langerhans cells. J Invest Dermatol 2012; 132:872-881.
2. Langerhans P. Uber die Nerven der menschlichen Haut. Virchows Archpathol 1868; 44:325-337.
3. Stingl G, Wolff-Schreiner EC, Pichler WJ, et al. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977; 268:245-246.
4. Klareskog L, Tjernlund U, Forsum U, Peterson PA. Epidermal Langerhans cells express Ia antigens. Nature 1977; 268:248-250.
5. Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282:324-336.
6. Schuler G, Romani N, Steinman RM. A comparison of murine epidermal Langerhans cells with spleen dendritic cells. J Invest Dermatol 1985; 85:99s-106s.
7. Romani N, Lenz A, Glassel H, et al. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989; 93:600-609.
8. van Furth R, Cohn ZA, Hirsch JG, et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull World Health Organ 1972; 46:845-852.
9. Guilliams M, Ginhoux F, Jakubzick C, et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol 2014; 14:571-578.
10. Anjuere F, del HoyoGM, Martin P, Ardavin C. Langerhans cells develop from a lymphoid-committed precursor. Blood 2000; 96:1633-1637.
11. Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 2002; 31:135-141.
12. Hieronymus T, Zenke M, Baek JH, Sere K. The clash of Langerhans cell homeostasis in skin: should I stay or should I go? Semin Cell Dev Biol 2015; 41:30-38.
13. Ginhoux F, Jung: S. Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat Rev Immunol 2014; 14:392-404.
14. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 2012; 13:753-760.
15. Greter M, Lelios I, Pelczar P, et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 2012; 37:1050-1060.
16. Ginhoux F, Greter M, Leboeuf M, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010; 330:841-845.
17. Hoeffel G, Wang Y, Greter M, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med 2012; 209:1167-1181.
18. Schulz C, Gomez Perdiguero E, Chorro L, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012; 336:86-90.
19. Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015; 518:547-551.
20. Hoeffel G, Chen J, Lavin Y, et al. C-myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 2015; 42:665-678.
21. Gomez Perdiguero E, Geissmann F. Myb-independent macrophages: a family of cells that develops with their tissue of residence and is involved in its homeostasis. Cold Spring Harb Symp Quant Biol 2013; 78:91-100.
22. Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014; 40:91-104.
23. Schuster C, Vaculik C, Fiala C, et al. HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigenpresenting cells. J Exp Med 2009; 206:169-181.
24. Schuster C, Vaculik C, Prior M, et al. Phenotypic characterization of leukocytes in prenatal human dermis. J Invest Dermatol 2012; 132:2581-2592.
25. Czernielewski JM, Demarchez M. Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J Invest Dermatol 1987; 88:17-20.
26. Kanitakis J, Morelon E, Petruzzo P, et al. Self-renewal capacity of human epidermal Langerhans cells: observations made on a composite tissue allograft. Exp Dermatol 2011; 20:145-146.
27. Collin M, Dickinson R, Bigley V. Haematopoietic and immune defects associated with GATA2 mutation. Br J Haematol 2015; 169:173-187.
28. Hambleton S, Salem S, Bustamante J, et al. IRF8 mutations and human dendritic-cell immunodeficiency. N Engl J Med 2011; 365:127-138.
29. Chopin M, Seillet C, Chevrier S, et al. Langerhans cells are generated by two distinct PU. 1-dependent transcriptional networks. J Exp Med 2013; 210:2967-2980.
30. Collin MP, Hart DN, Jackson GH, et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006; 203:27-33.
31. Auffermann-Gretzinger S, Eger L, Bornhauser M, et al. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation. Transplantation 2006; 81:866-873.
32. Mielcarek M, Kirkorian AY, Hackman RC, et al. Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation. Transplantation 2014; 98:563-568.
33. Andani R, Robertson I, Macdonald KP, et al. Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation. Exp Dermatol 2014; 23:75-77.
34. Merad M, Hoffmann P, Ranheim E, et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versushost disease. Nat Med 2004; 10:510-517.
35. Chorro L, Sarde A, Li M, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J Exp Med 2009; 206:3089-3100.
36. Bigley V, Haniffa M, Doulatov S, et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J Exp Med 2011; 208:227-234.
37. Ghigo C, Mondor I, Jorquera A, et al. Multicolor fate mapping of Langerhans cell homeostasis. J Exp Med 2013; 210:1657-1664.
38. Kellersch B, Brocker T. Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. Blood 2013; 121:298-307.
39. Sparber F, Scheffler JM, Amberg N, et al. The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood 2014; 123:217-227.
40. Sparber F, Tripp CH, Komenda K, et al. The late endosomal adaptor molecule p14 (LAMTOR2) regulates TGFbeta1-mediated homeostasis of Langerhans cells. J Invest Dermatol 2015; 135:119-129.
41. Strobl H, Riedl E, Scheinecker C, et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 1996; 157:1499-1507.
42. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996; 184:2417-2422.
43. Kaplan DH, Li MO, Jenison MC, et al. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med 2007; 204:2545-2552.
44. Kel JM, Girard-Madoux MJ, Reizis B, Clausen BE. TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis. J Immunol 2010; 185:3248-3255.
45. Zahner SP, Kel JM, Martina CA, et al. Conditional deletion of TGF-betaR1 using Langerin-Cre mice results in Langerhans cell deficiency and reduced contact hypersensitivity. J Immunol 2011; 187:5069-5076.
46. Yasmin N, Bauer T, Modak M, et al. Identification of bone morphogenetic protein 7 (BMP7) as an instructive factor for human epidermal Langerhans cell differentiation. J Exp Med 2013; 201:2597-2610.
47. Yasmin N, Konradi S, Eisenwort G, et al. Beta-catenin promotes the differentiation of epidermal Langerhans dendritic cells. J Invest Dermatol 2013; 133:1250-1259.
48. Bauer T, Zagorska A, Jurkin J, et al. Identification of Axl as a downstream effector of TGF-beta1 during Langerhans cell differentiation and epidermal homeostasis. J Exp Med 2012; 209:2033-2047.
49. Geissmann F, Dieu-Nosjean MC, Dezutter C, et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002; 196:417-430.
50. Ginhoux F, Tacke F, Angeli V, et al. Langerhans cells arise from monocytes in vivo. Nat Immunol 2006; 5:265-273.
51. Nagao K, Kobayashi T, Moro K, et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol 2012; 13:744-752.
52. Sere K, Baek JH, Ober-Blobaum J, et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 2012; 37:905-916.
53. Mende I, Karsunky H, Weissman IL, et al. Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood 2005; 107:1383-1390.
54. Geissmann F, Prost C, Monnet JP, et al. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998; 187:961-966.
55. Hutter C, Kauer M, Simonitsch-Klupp I, et al. Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells. Blood 2012; 120:5199-5208.
56. Martinez-Cingolani C, Grandclaudon M, Jeanmougin M, et al. Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-beta. Blood 2014; 124:2411-2420.
57. Milne P, Bigley V, Gunawan M, et al. CD1c+ blood dendritic cells have Langerhans cell potential. Blood 2015; 125:470-473.
58. Hoshino N, Katayama N, Shibasaki T, et al. A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol 2005; 78:921-929.
59. Ito T, Inaba M, Inaba K, et al. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 1999; 163:1409-1419.
60. MacDonald KPA, Munster D, Clark G, et al. Peripheral blood dendritic cell subset analysis. In: Mason D, editor. Leucocyte Typing VII. Oxford University Press; 2002; pp. 315-319.
61. Larregina AT, Morelli AE, Spencer LA, et al. Dermal-resident CD14+ cells differentiate into Langerhans cells. Nat Immunol 2001; 2:1151-1158.
62. McGovern N, Schlitzer A, Gunawan M, et al. Human dermal CD14(+) cells are a transient population of monocyte-derived macrophages. Immunity 2014; 41:465-477.
63. Bigley V, McGovern N, Milne P, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol 2015; 97:627-634.
64. Nelson DS, A van Halteren A, Quispel WT, et al. MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis. Genes Chromosomes Cancer 2015; 54:361-368.
65. Chakraborty R, Hampton OA, Shen X, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 2014; 124:3007-3015.
66. Brown NA, Furtado LV, Betz BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 2014; 124:1655-1658.